MeSH Browser

MeSH Supplementary: APO combination
Unique ID: C497334
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C497334
Registry Numbers: 0
Heading Mapped to: *Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Methotrexate; Prednisone; Vincristine; Mercaptopurine
Frequency: 1
Note: chemotherapy protocol consisting of above cpds for treating advanced-stage large-cell lymphoma; has been called APO regimen, but do not confuse with SCR of same name
Source: J Clin Oncol 2005 Jan 20;23(3):541-7
Date of Entry: 2005/03/09
Revision Date: 2005/03/09

APO combination MeSH Supplementary Concept Data 2025